Medication info
Singulair Chewable Tablet 5 mg (Montelukast Sodium)

Singulair Chewable Tablet 5 mg (Montelukast Sodium)

Prescription medicationChewable TabletOral
Ingredient · strength
Montelukast Sodium›5.2mg / 1 tablet
Manufacturer / importer
Allico Pharmaceutical Co., Ltd.
Appearance
Pink, biconvex, round chewable tablet
Packaging
28 tablets (7 tablets/PTP × 4)
Approval status
Active

MFDS item code 201508160 · Approved 2015.11.26 · Insurance code 656004040

Summary

Main use
Prevention and maintenance treatment of asthma; relief of symptoms of seasonal and perennial allergic rhinitis
Who takes it
Adults · Children
Adult dose
Take this product once daily. Patients with asthma should take it in the evening; for patients with allergic rhinitis, determine the dosing time according to the patient's condition. Patients with both asthma and allergic rhinitis should take 1 tablet once daily in the evening. Adults and adolescents 15 years of age and older: Administer 10 mg of montelukast orally once daily.
Child dose
Children aged 6~14 years: Take 5 mg of montelukast once daily by chewing. Administer this medicine 1 hour before or 2 hours after a meal. Children aged 2~5 years: Take 4 mg of montelukast once daily by chewing. Administer this medicine 1 hour before or 2 hours after a meal.

Ingredients

Manufacturer
Allico Pharmaceutical Co., Ltd.

Efficacy & effects

Prevention and maintenance treatment of asthma; relief of symptoms of seasonal and perennial allergic rhinitis

  • Asthma
  • allergic rhinitis symptoms
View approved original text

This medication helps to prevent the occurrence of asthma and treat ongoing symptoms. It is also used to relieve symptoms of seasonal and perennial allergic rhinitis. It is effective for improving symptoms in patients suffering from asthma and allergic rhinitis.

How to take

Adult dose

Take this product once daily. Patients with asthma should take it in the evening; for patients with allergic rhinitis, determine the dosing time according to the patient's condition. Patients with both asthma and allergic rhinitis should take 1 tablet once daily in the evening. Adults and adolescents 15 years of age and older: Administer 10 mg of montelukast orally once daily.

Child dose

Children aged 6~14 years: Take 5 mg of montelukast once daily by chewing. Administer this medicine 1 hour before or 2 hours after a meal. Children aged 2~5 years: Take 4 mg of montelukast once daily by chewing. Administer this medicine 1 hour before or 2 hours after a meal.

Precautions

This medication contains the artificial sweetener aspartame, which requires metabolism of phenylalanine in the body. Therefore, patients with phenylketonuria, a hereditary disease, should not take this medication, and care should be taken not to exceed the daily intake recommended by the WHO for aspartame. This medication may cause allergic reactions; hence, patients who are hypersensitive to this drug or its components should not take it. Additionally, because it contains lactose, patients with genetic disorders such as galactose intolerance, lactase deficiency, or glucose-galactose malabsorption should not take it. This medication is not used as a bronchodilator for acute asthma attacks, and appropriate emergency medications should always be kept on hand. It can continue to be taken during an asthma exacerbation; however, the dosage of inhaled corticosteroids should not be suddenly reduced or changed to this medication. During treatment, neurological or psychiatric symptoms, such as agitation, anxiety, depression, or hallucinations, may occur, and if any abnormal symptoms arise, one should consult a physician. Patients with exercise-induced bronchoconstriction should not use this medication alone and should prepare a short-acting inhaled bronchodilator for emergencies. Patients allergic to aspirin should not take aspirin or non-steroidal anti-inflammatory drugs while on this medication. Rarely, systemic eosinophilia and vasculitis symptoms may occur; if symptoms worsen, immediate medical attention should be sought. This medication is known not to increase adverse reactions when used with other asthma treatments, but one should consult a physician regarding the possibility of interactions with specific drugs. Pregnant women should take it only when clearly needed, and nursing mothers should be cautious as this medication may be secreted in breast milk. It can be used safely in children and the elderly; however, safety has not been established for children under 6 months or during pregnancy. In case of overdose, there is no specific antidote available, and general treatment should be administered according to symptoms. It should be stored out of the reach of children. Lastly, this medication should be taken consistently even when symptoms are absent, and in the case of acute exacerbation, one must consult a physician and have emergency medication ready.

Side effects

Asthenia, fatigue, fever, abdominal pain, trauma, dyspepsia, infectious gastroenteritis, toothache, dizziness, headache, nasal congestion, cough, influenza, rash, increased ALT, increased AST, pyuria, pharyngitis, sinusitis, nausea, diarrhea, loss of appetite, otitis, viral infection, laryngitis, allergic rhinitis, chickenpox, gastroenteritis, atopic dermatitis, acute bronchitis, dental infection, skin infection, myopia, ear pain, enteritis, eczema, urticaria, pneumonia, dermatitis, conjunctivitis, upper respiratory tract infection, wheezing, otitis media, tonsillitis, drowsiness, aggressive behavior, anxiety, depression, disorientation, attention disorder, sleep disorder, hallucinations, insomnia, memory impairment, psychomotor hyperactivity, sleepwalking, suicidal impulses, behavioral disorders, tics, perceptual disturbances, sensory decline, convulsions, palpitations, epistaxis, pulmonary eosinophilia, vomiting, cholestatic hepatitis, hepatocellular liver damage, mixed liver damage, angioedema, bruising, erythema multiforme, nodular erythema, itching, toxic epidermal necrolysis, Stevens-Johnson syndrome, arthralgia, muscle cramps, myalgia, enuresis, edema, systemic eosinophilia, vasculitis-related rash, worsening pulmonary symptoms, cardiac complications, neuropathy, increased incidence of bleeding, thrombocytopenia, hypersensitivity reactions, anxiety including aggressive behavior or hostility, depression, disorientation, attention disorder, sleep disorder and hallucinations, insomnia, memory impairment, psychomotor hyperactivity, sleepwalking, suicidal impulses and behavior, tics

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container that prevents air and moisture from entering, and it is important to store it away from direct sunlight. The storage temperature should be maintained at room temperature, between 1 degree and 30 degrees.

Appearance and packaging

Appearance

Pink, biconvex, round chewable tablet

Package unit

28 tablets (7 tablets/PTP × 4)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.